Fundraising Fox

Edwards Lifesciences

NYSE: EW

Irvine, US · Delaware corporation · 2 known investors

edwards.com ↗
BiotechHealthtechMedical Devices

Founders & leadership

DE
Donald E. Bobo, Jr.Executive
SB
Scott B. UllemExecutive
LL
Larry L. WoodExecutive
HW
Huimin WangExecutive
CM
Catherine M. SzymanExecutive
BJBernard J. Zovighian
Bernard J. ZovighianExecutive

Board

WJ
William J. LinkBoard director
NJ
Nicholas J. ValerianiBoard director
SR
Steven R. LorangerBoard director
WW
Wesley W. von SchackBoard director
LS
Leslie S. HeiszBoard director
JT
John T. CardisBoard director

Investors · 2

ALIVE Israel HealthTech FundSavyon
Versant Venture AIV HoldingsreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$307.2M disclosed across 2 rounds · 2017–2018

▶$34.9MraisedJun 2018 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William J. LinkDirector
  • Kieran T. GallahueDirector
  • Jean-Luc LemercierExecutive Officer
  • Leslie S. HeiszDirector
  • Donald E. Bobo, Jr.Executive Officer
  • Nicholas J. ValerianiDirector
  • Steven R. LorangerDirector
  • Wesley W. von SchackDirector
  • Martha H. MarshDirector
  • Catherine M. SzymanExecutive Officer
  • Larry L. WoodExecutive Officer
  • Michael A. MussallemExecutive Officer, Director
  • Huimin WangExecutive Officer
  • Scott B. UllemExecutive Officer
Offering amount
$34.9M
Amount sold
$34.9M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$272.4MraisedFeb 2017 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas J. ValerianiDirector
  • William J. LinkDirector
  • Steven R. LorangerDirector
  • Donald E. Bobo, Jr.Executive Officer
  • Wesley W. von SchackDirector
  • Scott B. UllemExecutive Officer
  • Larry L. WoodExecutive Officer
  • Leslie S. HeiszDirector
  • Huimin WangExecutive Officer
  • Catherine M. SzymanExecutive Officer
  • John T. CardisDirector
  • Bernard J. ZovighianExecutive Officer
  • Michael A. MussallemExecutive Officer, Director
  • Patrick VerguetExecutive Officer
  • Kieran GallahueDirector
  • Martha H. MarshDirector
Offering amount
$272.4M
Amount sold
$272.4M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Edwards Lifesciences went on to found or lead other companies.

Todd BrintonChief Scientific Officer & Corporate Vice PresidentFounded Shockwave MedicalTak CheungDirector, Business DevelopmentFounded Lexington Medical, Inc

Competitors · 1

by search overlap
Rf Surgical663 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies competing with Edwards Lifesciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals
Harpoon Medical, Inc.

University of Maryland spin-out commercializing minimally invasive image-guided surgical tool for beating heart mitral valve repair (acquired by Edwards Lifesciences in December 2017).

Frequently asked questions

Who are Edwards Lifesciences's investors?
Edwards Lifesciences's investors include ALIVE Israel HealthTech Fund, Versant Venture AIV Holdings.
How much funding has Edwards Lifesciences raised?
Edwards Lifesciences has disclosed $307.2M raised across 2 rounds.
Where is Edwards Lifesciences headquartered?
Edwards Lifesciences is headquartered in Irvine, US.